» Articles » PMID: 32655968

The Roles of CCR7 for the Homing of Memory CD8+ T Cells into Their Survival Niches

Overview
Journal Immune Netw
Date 2020 Jul 14
PMID 32655968
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Memory CD8+ T cells in the immune system are responsible for the removal of external Ags for a long period of time to protect against re-infection. Naïve to memory CD8+ T cell differentiation and memory CD8+ T cell maintenance require many different factors including local environmental factors. Thus, it has been suggested that the migration of memory CD8+ T cells into specific microenvironments alters their longevity and functions. In this review, we have summarized the subsets of memory CD8+ T cells based on their migratory capacities and described the niche hypothesis for their survival. In addition, the basic roles of CCR7 in conjunction with the migration of memory CD8+ T cells and recent understandings of their survival niches have been introduced. Finally, the applications of altering CCR7 signaling have been discussed.

Citing Articles

A novel anti-mouse CCR7 monoclonal antibody, CMab-7, demonstrates high sensitivity in flow cytometry, western blot, and immunohistochemistry.

Satofuka H, Suzuki H, Tanaka T, Ubukata R, Hirose M, Yamamoto H Biochem Biophys Rep. 2025; 41:101948.

PMID: 40028039 PMC: 11870228. DOI: 10.1016/j.bbrep.2025.101948.


Combined PARP14 inhibition and PD-1 blockade promotes cytotoxic T cell quiescence and modulates macrophage polarization in relapsed melanoma.

Leshem R, Sefton K, Wong C, Lin I, Isaac D, Niepel M J Immunother Cancer. 2025; 13(1).

PMID: 39870492 PMC: 11772928. DOI: 10.1136/jitc-2024-010683.


Peripheral immune characteristics and subset disorder in reproductive females with endometriosis.

Lin K, Li P, Zhu X, Mao X, Peng J, Chen X Front Immunol. 2024; 15:1431175.

PMID: 39669572 PMC: 11634862. DOI: 10.3389/fimmu.2024.1431175.


CAR T-cells for pediatric solid tumors: where to go from here?.

Trautmann T, Yakobian N, Nguyen R Cancer Metastasis Rev. 2024; 43(4):1445-1461.

PMID: 39317919 PMC: 11554711. DOI: 10.1007/s10555-024-10214-6.


Fueling CARs: metabolic strategies to enhance CAR T-cell therapy.

Van der Vreken A, Vanderkerken K, de Bruyne E, de Veirman K, Breckpot K, Menu E Exp Hematol Oncol. 2024; 13(1):66.

PMID: 38987856 PMC: 11238373. DOI: 10.1186/s40164-024-00535-1.


References
1.
Maude S, Frey N, Shaw P, Aplenc R, Barrett D, Bunin N . Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014; 371(16):1507-17. PMC: 4267531. DOI: 10.1056/NEJMoa1407222. View

2.
Yeon S, Choi A, Hong M, Jung Y . Mediators of the homeostasis and effector functions of memory Th2 cells as novel drug targets in intractable chronic allergic diseases. Arch Pharm Res. 2019; 42(9):754-765. DOI: 10.1007/s12272-019-01159-4. View

3.
Burgstahler R, Kempkes B, Steube K, Lipp M . Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Biochem Biophys Res Commun. 1995; 215(2):737-43. DOI: 10.1006/bbrc.1995.2525. View

4.
Johnson E, Cole G . Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. J Exp Med. 1975; 141(4):866-81. PMC: 2189749. View

5.
Dauner J, Williams I, Jacob J . Differential microenvironment localization of effector and memory CD8 T cells. J Immunol. 2007; 180(1):291-9. DOI: 10.4049/jimmunol.180.1.291. View